The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


BCG medac, powder and solvent for intravesical suspension

Powder + Solvent/Suspension/Intravesical Use

medac Gesellschaft für klinische Spezialpräparate mbHPA0623/004/001

Main Information

Trade NameBCG medac, powder and solvent for intravesical suspension
Active SubstancesBacillus Calmette Guérin (BCG)
Strength
Dosage FormPowder + Solvent/Suspension/Intravesical Use
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberPA0623/004/001

Group Information

ATC CodeL03AX Other immunostimulants
L03AX03 BCG vaccine

Status

Authorised/WithdrawnAuthorised
Licence Issued05/04/2002
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - Patient

« Back